PerkinElmer, Inc.

719 articles with PerkinElmer, Inc.

• PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)

  11/2/2020

  Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine

• 

  PerkinElmer Expands Horizons with $383 Million CRISPR Tech Acquisition

  11/2/2020

  Horizon Discovery Group brings new gene editing and gene modulation tools to PerkinElmer’s expanding life sciences portfolio.

• PerkinElmer Announces Financial Results for the Third Quarter of 2020

  10/28/2020

  PerkinElmer, Inc . (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020. The Company reported GAAP earnings per share from continuing operations of $1.57, as comp

• PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

  10/26/2020

  PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD). This test is currently under review b

• PerkinElmer Board Declares Quarterly Dividend - Oct 22, 2020

  10/22/2020

  The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock October 22, 2020.

• PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds Capable of Disrupting the SARS-CoV-2 Spike Protein/ACE2 Interaction

  10/20/2020

  PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that a research team at the National Center for Advancing Translational Sciences (NCATS), an arm of the National Institutes of Health (NIH), is working with PerkinElmer’s AlphaLISA ® immunoassay to

• CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

  10/12/2020

  Oct. 12, 2020 14:09 UTC CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020

• Newport, Wales Laboratory Goes Live as First Lighthouse Lab featuring PerkinElmer’s COVID-19 Solutions

  10/8/2020

  PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that the first Turnkey Lighthouse lab in Newport, South Wales, is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in

• PerkinElmer Launches Industry First, Fully Automated Workflow for Cannabis & Hemp Pesticide Residue Testing

  10/7/2020

  Streamlined solution features quality control reagent kits, robotic sample preparation, mass spectrometry analysis and data reporting software to transform analysis efficiency WALTHAM, Mass.--( BUSINESS WIRE )-- PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the cannabis industry’s first fully-automated liquid handling sample preparation and LC/MS/MS analysis workflow for pesticide residue testing

• PerkinElmer EONIS Screening Test Receives CE-IVD Clearance

  9/30/2020

  PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that the Company’s EONIS™ screening assay for newborns that simultaneously tests for SMA (spinal muscular atrophy), SCID (severe combined immunodeficiency) and XLA (X-linked agammaglobulinemia) has receiv

• PerkinElmer Launches Solus Listeria monocytogenes ELISA Assay for Testing Across Food and Environmental Samples

  9/21/2020

  PerkinElmer Launches Solus Listeria monocytogenes ELISA Assay for Testing Across Food and Environmental Samples Solution Receives AOAC ® PTM SM Certification

• PerkinElmer Launches DA 7350™ Instrument and Cloud-Based Software for Quality Control in Food Production

  9/15/2020

  PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today introduced the DA 7350™ instrument and Process Plus™ cloud-based software to provide continuous quality control for food and food ingredient manufacturing processes. The new solution is designed to enable food producers to

• PerkinElmer to Present at BofA Global Healthcare Conference 2020

  9/4/2020

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Global Healthcare Conference 2020 on Wednesday, September 16, 2020 at 10:05 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview of the Company and it

• PerkinElmer to Present at Baird's 2020 Virtual Global Healthcare Conference

  8/19/2020

  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Baird's 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020 at 8:30 a.m. ET. Jamey Mock, senior vice president and chief financial officer for PerkinElmer, will provide an overview of the Company and its strategic priorities. A live audio webcast o

• PerkinElmer Enhances Hand Sanitizer Analyzer to Detect Methanol in 30 Seconds or Less

  8/17/2020

  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail results delivered in 30 seconds or less. Recent warnings and recal

• PerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection

  8/17/2020

  PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a series of explorer™ workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day. These modular and scalable workstations enable laboratories to ramp up SARS-CoV-2 tes

• PerkinElmer Board Declares Quarterly Dividend - July 23, 2020

  7/23/2020

  The Board of Directors of PerkinElmer, Inc., declared a regular quarterly dividend of $0.07 per share of common stock July 23, 2020.

• PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

  7/22/2020

  PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access PerkinElmer COVID-19 Data Dashboards to help the global scientific community accelerate the discovery of COVID-19 antivirals and vaccines. These dashboards are powered

• PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test

  7/21/2020

  PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP ® /DELFIA ® platform, enabling processing of up to 5,000 samples per day. The finger-prick

• PerkinElmer Introduces AuroFlow® AQ Mycotoxin Platform to Support Testing for Top Six Regulated Mycotoxins in Grain Commodities

  7/20/2020

  PerkinElmer Introduces AuroFlow ® AQ Mycotoxin Platform to Support Testing for Top Six Regulated Mycotoxins in Grain Commodities Features water-based testing strips and handheld reader delivering convenience and accuracy